Anixa Biosciences Ratios and Metrics

Market cap in millions EUR. Fiscal year is November - October.

Millions EUR. Fiscal year is Nov - Oct.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 29, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Market Capitalization	85	118	104	93	174	124
Market Cap Growth	19.71%	13.63%	11.62%	-46.48%	40.55%	193.79%
Enterprise Value	72	103	84	68	141	91
Last Close Price	2.54	3.62	3.26	2.96	5.44	4.04
PS Ratio	-	-	-	467.53	-	279.02
PB Ratio	7.06	9.74	5.96	4.20	6.09	4.11
P/TBV Ratio	6.50	8.97	5.63	4.03	5.91	4.03
EV/Sales Ratio	-	-	-	342.38	-	206.32
Debt / Equity Ratio	0.02	0.02	0.01	0.01	0.01	0.01
Asset Turnover	-	-	-	0.01	-	0.02
Quick Ratio	7.71	7.71	8.04	11.89	14.60	28.13
Current Ratio	8.08	8.08	8.55	12.50	14.83	28.35
Return on Equity (ROE)	-67.17%	-67.17%	-60.10%	-38.51%	-43.74%	-61.02%
Return on Assets (ROA)	-38.83%	-38.83%	-36.70%	-24.61%	-26.02%	-35.92%
Return on Capital Employed (ROCE)	-82.90%	-82.90%	-72.40%	-46.90%	-48.90%	-37.50%
Earnings Yield	-11.09%	-8.04%	-11.15%	-9.99%	-7.92%	-9.07%
FCF Yield	-	-5.28%	-6.51%	-6.32%	-3.78%	-3.46%
Buyback Yield / Dilution	-1.74%	-1.74%	-2.96%	-1.99%	-6.28%	-28.57%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.